Clinical trial
Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis
NCT01998334 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2012
- Completion date
- December 31, 2016
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis